Oizumi et al.
JOCNote
1H NMR (500 MHz, CDCl3, Me4Si, 1:1 mixture of rotational
isomers) δ 7.49-7.12 (40H, m), 6.98-6.67 (5.5H, m), 6.43 (0.5H,
dd, J = 8.3, 1.7 Hz), 6.25 (0.5H, s), 6.23 (0.5H, d, J = 2.3 Hz), 6.20
(0.5H, d, J = 2.3 Hz), 6.14 (0.5H, d, J = 2.3 Hz), 6.11 (0.5H, d,
J = 2.3 Hz), 5.99 (0.5H, s), 5.98 (0.5H, s), 5.86 (0.5H, t, J = 9.6
Hz), 5.22-4.54 (18.5H, m), 3.93 (0.5H, m), 3.58 (0.5H, m), 3.37
(0.5H, d, J=8.8Hz), 3.04(0.5H, dd, J= 16.2, 5.7 Hz), 2.86 (0.5H,
dd, J = 16.5, 5.0 Hz), 2.73 (0.5H, dd, J = 16.5, 7.0 Hz), 2.35 (0.5H,
dd, J = 16.1, 9.6 Hz), 2.17 (0.5H, m), 1.62 (1.5H, s), 1.54 (1.5H, s);
13C NMR (125 MHz, CDCl3, Me4Si, 1:1 mixture of rotational
isomers) δ 169.3, 168.7, 158.2, 158.1, 157.8, 156.8, 156.7, 156.5,
155.9, 155.8, 155.5, 153.7, 152.5, 149.3, 149.0, 149.0, 148.9 (2 ꢀ C),
148.8, 148.6, 138.0, 137.4, 137.3 (3 ꢀ C), 137.2, 137.1, 137.0
(2 ꢀ C), 136.8, 136.6, 131.8, 131.6, 130.9, 128.5, (2 ꢀ C), 128.4
(3 ꢀ C), 128.3 (3 ꢀ C), 128.1, 128.0 (2 ꢀ C), 127.82 (2 ꢀ C), 127.7,
127.6, 127.5 (3 ꢀ C), 127.4, 127.3 (3 ꢀ C), 127.2 (2 ꢀ C), 127.1,
127.0, 126.9, 121.3, 120.9, 120.3, 120.1, 115.0, 114.8, 114.6, 114.5,
114.2, 114.1, 113.7, 110.7, 110.3, 108.3, 107.9, 102.3 (2 ꢀ C), 94.9
(2 ꢀ C), 94.4, 94.3, 91.2 (2 ꢀ C), 80.6, 80.2, 80.1, 79.9, 71.6, 71.5,
71.4, 71.3, 71.2, 70.4, 70.3, 70.0 (2 ꢀ C), 69.8, 68.8, 67.8, 35.4,
35.2, 28.6, 26.5, 20.7, 20.4; HRMS (FAB) calcd for C88H77O13
[M þ H]þ 1341.5364, found 1341.5381.
149.3, 149.2, 149.0, 148.7, 137.7, 137.3 (2 ꢀ C), 137.2, 137.1, 137.0,
136.7, 131.9, 131.7, 128.6, 128.5 (3 ꢀ C), 128.4 (3 ꢀ C), 128.3,
128.2, 128.1, 127.9, 127.8 (2 ꢀ C), 127.8 (2 ꢀ C), 127.7 (2 ꢀ
C),127.6 (2 ꢀ C), 127.51 (2 ꢀ C), 127.4, 127.3, 127.2 (2 ꢀ C) 127.1
(3 ꢀ C), 121.3, 120.8, 120.7, 120.1, 115.2, 115.0 (2 ꢀ C), 114.7,
114.2, 113.9, 113.7, 112.2, 108.7, 108.5, 102.5, 95.0, 94.2, 91.9, 91.6,
82.1, 81.8, 81.3, 80.7, 73.4, 73.3, 71.4, 71.2 (3 ꢀ C), 71.04, 70.4, 70.1,
70.0 (2 ꢀ C), 69.9, 68.5, 68.4.
Procyanidin B3 (1). Compound 10 (30 mg, 0.023 mol) and
Pd(OH)2 on carbon (20 wt %, 6 mg) in THF/MeOH/H2O
(20:1:1, 5 mL) was stirred for 48 h under H2 atmosphere. After
the reaction had been completed, the mixture was filtered and
the solvent was evaporated. The residue was purified with ODS
cartridge column chromatography (MeOH/H2O = 3:7) to give
1 (10 mg, 87%) as a colorless solid: mp 218-219 °C (decomp.);
[R]27D -181 (c 0.29, EtOH); 1H NMR (500 MHz, CDCl3, Me4Si,
2:1 mixture of rotational isomers) δ 6.96 (0.67H, d, J = 1.9 Hz),
6.80 (0.33H, dd, J = 8.2, 1.9 Hz), 6.78 (0.33H, dd, J = 8.2, 1.9
Hz), 6.75 (0.67H, dd, J = 8.2, 1.9 Hz), 6.74 (0.67H, d, J = 1.9
Hz), 6.68 (1.33H, d, J = 8.2 Hz), 6.58 (0.67H, d, J = 1.9 Hz),
6.48 (0.67H, J = 8.2, 1.9 Hz), 6.26 (0.67H, dd, J = 8.2, 1.8 Hz),
6.08 (0.67H, s), 5.95 (0.33H, s), 5.89 (0.67H, d, J = 2.4 Hz), 5.85
(0.33H, J = 2.3 Hz), 5.82 (0.33H, d, J = 2.4 Hz), 5.79 (0.67H, d,
J = 2.4 Hz), 4.75 (0.33H, d, J = 7.2 Hz), 4.54 (0.67H, d, J = 7.3
Hz), 4.41 (1H, d, J = 7.8 Hz), 4.35 (1H, dd, J = 9.6, 7.9 Hz), 4.26
(1H, d, J = 9.7 Hz), 4.08 (0.33H, m), 3.78 (0.67H, m), 2.82
(0.33H, dd, J = 16.1, 5.6 Hz), 2.76 (0.67H, dd, J = 16.2, 5.5 Hz),
2.59 (0.33H, dd, J = 16.1, 7.4 Hz), 2.49 (0.67H, dd, J = 16.2,
8.0 Hz); 13C NMR (125 MHz, CD3OD, Me4Si, 2:1 mixture
of rotational isomers) δ 159.9, 158.7, 157.4, 157.3, 157.2, 156.0,
155.9, 155.8, 155.7, 155.1, 154.9, 146.2, 146.2, 145.8, 145.7,
145.5, 132.7, 132.5, 131.9, 121.19, 120.7, 120.2, 120.0, 116.5,
116.3, 116.2, 116.1, 116.0, 115.6, 115.3, 108.4, 108.2, 107.3
(2 ꢀ C), 102.3, 100.6, 97.6, 97.4, 97.0, 96.3, 96.2, 84.1, 84.0, 83.0
(2 ꢀ C), 73.7, 68.9, 68.6, 38.6, 28.8, 28.5; HRMS (FAB) calcd for
C30H25O12 [M - H]- 577.1346, found 577.1358.
[4,8]-2,3-trans-3,4-trans-20,30-trans-Octa-O-benzyl-bi-(þ)-
catechin (10).3b,8. To a solution of R-9 (39 mg, 0.029 mmol) in
MeOH (5 mL) was added K2CO3 (78 mg, 0.55 mmol). After being
stirred for 12 h, the mixture was diluted with water and extracted
with Et2O. The organic layer was washed with water and brine and
dried with MgSO4. The solvent was evaporated, and the residue
was purified with preparative TLC (hexane/AcOEt/CH2Cl2 =
4:1:2) to afford 10 (30 mg, 82%) as an amorphous solid: [R]24
D
-127.5 (c 1.00, CHCl3); IR (film) 3567, 3062, 3031, 2928, 2869,
1606, 1510, 1498, 1454, 1426, 1377, 1264, 1215, 1177, 1112, 1062,
1
1026, 910, 850, 809, 736, 697, 623 cm-1; H NMR (500 MHz,
CD3OD, Me4Si, 2:1 mixture of rotational isomers) δ 7.49-7.15
(40H, m), 7.04-6.47 (6H, m), 6.31 (0.67H, s), 6.23 (0.33H, d, J =
2.3 Hz), 6.20 (0.67H, d, J = 2.3 Hz), 6.13 (1H, d, J = 2.4 Hz), 6.04
(0.33H, d, J = 2.3 Hz), 5.20-4.48 (18H, m), 4.32 (0.67H, m), 4.20
(0.33H, m), 3.73 (0.5H, m), 3.67 (1H, d, J = 8.5 Hz), 3.20 (0.33H,
dd, J = 16.4, 5.9 Hz), 3.08 (0.67H, dd, J = 16.2, 5.6 Hz), 2.68
(0.33H, dd, J = 16.4, 9.4 Hz), 2.42 (0.67H, dd, J = 16.2, 9.1 Hz);
13C NMR (125 MHz, CDCl3, Me4Si, 2:1 mixture of rotational
isomers) δ 158.0, 157.7, 157.0, 156.8, 155.6, 155.5, 153.9, 152.9,
Supporting Information Available: Experimental procedure
1
of synthesis of diacetate of 10 and anti-inflammatory test. H
and 13C NMR spectra of R-9, 10, and 1, and 1H NMR spectrum
of diacetate of 10. This material is available free of charge via the
4886 J. Org. Chem. Vol. 75, No. 14, 2010